Lack of effect of genetic polymorphisms of SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients

作者： Guo-ping Yang , Hong Yuan , Bin Tang , Wei Zhang , Lian-sheng Wang

关键词:

摘要: Lack of effect genetic polymorphisms SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients

参考文章(26)

SLCO1B1 variants and statin-induced myopathy--a genomewide study The New England Journal of Medicine. ,vol. 359, pp. 789- 799 ,(2008) , 10.1056/NEJMOA0801936

Jörg König, Yunhai Cui, Anne T. Nies, Dietrich Keppler, A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane American Journal of Physiology-gastrointestinal and Liver Physiology. ,vol. 278, ,(2000) , 10.1152/AJPGI.2000.278.1.G156

J F Thompson, M Man, K J Johnson, L S Wood, M E Lira, D B Lloyd, P Banerjee, P M Milos, S P Myrand, J Paulauskis, M A Milad, W J Sasiela, An association study of 43 SNPs in 16 candidate genes with atorvastatin response Pharmacogenomics Journal. ,vol. 5, pp. 352- 358 ,(2005) , 10.1038/SJ.TPJ.6500328

M IGEL, K ARNOLD, M NIEMI, U HOFMANN, M SCHWAB, D LUTJOHANN, K VONBERGMANN, M EICHELBAUM, K KIVISTO, Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin. Clinical Pharmacology & Therapeutics. ,vol. 79, pp. 419- 426 ,(2006) , 10.1016/J.CLPT.2006.01.010

Jessica Mwinyi, Andreas Johne, Steffen Bauer, Ivar Roots, Thomas Gerloff, Evidence for Inverse Effects of OATP-C (SLC21A6) *5 and *1b Haplotypes on Pravastatin Kinetics Clinical Pharmacology & Therapeutics. ,vol. 75, pp. 415- 421 ,(2004) , 10.1016/J.CLPT.2003.12.016

Hiroshi Takane, Masanori Miyata, Naoto Burioka, Chiaki Shigemasa, Eiji Shimizu, Kenji Otsubo, Ichiro Ieiri, Pharmacogenetic determinants of variability in lipid-lowering response to pravastatin therapy Journal of Human Genetics. ,vol. 51, pp. 822- 826 ,(2006) , 10.1007/S10038-006-0025-1

Mikko Niemi, Kari T. Kivisto, Ute Hofmann, Matthias Schwab, Michel Eichelbaum, Martin F. Fromm, Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1). British Journal of Clinical Pharmacology. ,vol. 59, pp. 602- 604 ,(2005) , 10.1111/J.1365-2125.2005.02354.X

JH Choi, MG Lee, J-Y Cho, J-E Lee, KH Kim, K Park, Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans. Clinical Pharmacology & Therapeutics. ,vol. 83, pp. 251- 257 ,(2008) , 10.1038/SJ.CLPT.6100267